The invention relates to a medicinal composition comprising a triazine derivative of the following general formula \x9bI! ##STR1## or a solvate thereof, or a salt thereof, as an active ingredient. In the above formula, R.sup.1 and R.sup.2 may be the same or different and each represents hydrogen, unsubstituted or substituted alkyl aralkyl, or alkenyl, or jointly represent cyclic amino (NR.sup.1 R.sup.2) in combination with the adjacent nitrogen atom. The cyclic amino may contain nitrogen, oxygen, or sulfur as a ring member in addition to the adjacent nitrogen and may be further substituted. Excluded is the case in which NR.sup.1 R.sup.2 is NH.sub.2. The compound of the invention is useful as a therapeutic drug for hepatitis.
该发明涉及一种药物组合物,其包括以下一般式的三嗪衍
生物\x9bI! ##STR1## 或其溶剂化物,或其盐,作为活性成分。在上述式中,R.sup.1和R.sup.2可以相同也可以不同,每个代表氢,未取代或取代的烷基芳基,或烯基,或者共同代表与相邻氮原子结合的环状
氨基(NR.sup.1 R.sup.2)。该环状
氨基除了相邻氮原子外,还可以包含氮、氧或
硫作为环成员,并且可能进一步取代。不包括NR.sup.1 R.sup.2为NH.sub.2的情况。该发明的化合物可用作治疗肝炎的治疗药物。